Speaking ahead of an investor day, the for-profit system said Nov. 9 it is also expecting diluted earnings per share growth of between 8% and 12% in the same period.
“While our planning process for 2024 is not complete, we currently believe that our 2024 expectations will fall within the targeted ranges above,” CEO Sam Hazen said in a statement.
The predictions also take into account disputed claims with a commercial payer, HCA said. Fuller 2024 guidance is expected at the release of the system’s next financial results in January.
HCA reported third-quarter operating income of $1.63 billion on revenue of $16.21 billion. Adjusted EBITDA for the quarter was slightly down on the same period in 2022, totaling $2.88 billion.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.